Literature DB >> 27693329

Nonsteroidal Anti-inflammatory Drugs for Prevention of Post-ERCP Pancreatitis: Sooner Rather Than Later during ERCP?

Gregory A Coté1, B Joseph Elmunzer1.   

Abstract

Entities:  

Year:  2016        PMID： 27693329     DOI： 10.1053/j.gastro.2016.09.026

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  Rectally administered indomethacin to prevent post-ESWL-pancreatitis (RIPEP): study protocol for a randomized controlled trial.

Authors:  Yang-Yang Qian; Hui Chen; Xin-Ying Tang; Xi Jiang; Wei Qian; Wen-Bin Zou; Lei Xin; Bo Li; Yan-Fen Qi; Liang-Hao Hu; Duo-Wu Zou; Zhen-Dong Jin; Dong Wang; Yi-Qi Du; Luo-Wei Wang; Feng Liu; Zhao-Shen Li; Zhuan Liao
Journal:  Trials       Date:  2017-11-02       Impact factor: 2.279

2.  Optimal timing of rectal diclofenac in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Christina J Sperna Weiland; Xavier J N M Smeets; Robert C Verdonk; Alexander C Poen; Abha Bhalla; Niels G Venneman; Wietske Kievit; Hester C Timmerhuis; Devica S Umans; Jeanin E van Hooft; Marc G Besselink; Hjalmar C van Santvoort; Paul Fockens; Marco J Bruno; Joost P H Drenth; Erwin J M van Geenen
Journal:  Endosc Int Open       Date:  2022-03-14

3.  Chronic Use of Statins and Their Effect on Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.

Authors:  Mahmud Mahamid; Abdulla Watad; Nicola L Bragazzi; Dov Wengrower; Julie Wolff; Dan Livovsky; Howard Amital; Mohammad Adawi; Eran Goldin
Journal:  Front Pharmacol       Date:  2018-06-29       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.